Ann Czarnik, M.D.

Ann Czarnik, M.D., FACEP is a board-certified Emergency Medicine physician and Fellow of the American College of Emergency Physicians. She earned her medical degree from the Medical College of Virginia, where she was elected to Alpha Omega Alpha. She completed her Emergency Medicine residency at Johns Hopkins University, where she served as Chief Resident. Dr. Czarnik spent nearly 17 years practicing emergency medicine in Austin, Texas, including nearly a decade as Assistant Program Director for the Emergency Medicine residency at Dell Medical School at The University of Texas at Austin. She held faculty appointments at both UT Austin and UT Southwestern and completed the ACEP Teaching Fellowship. She co-founded Amanecia Health to deliver physician-led concierge medicine.

Ann Czarnik, M.D., board-certified emergency medicine physician and co-founder of Amanecia Health Austin
Ann Czarnik, M.D. | Amanecia Health

Oral GLP-1 Medications Are Here. What Patients Should Know.

Austin, National, Weight Loss Medication

By Ann Czarnik, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health For the past two years, GLP-1 medications have changed the way physicians approach weight management. Semaglutide and tirzepatide, delivered as weekly injections, have helped millions of patients achieve meaningful, sustained weight loss under medical supervision. Now there is a new chapter. Two oral […]

Oral GLP-1 Medications Are Here. What Patients Should Know. Read More »

Dr. Ann Czarnik, M.D., board-certified Emergency Medicine physician, Amanecia Health

Med Spa, Telehealth App, or Physician? Why Your Weight Loss Doctor’s Background Matters

National, Weight Loss Medication

By Ann Czarnik, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health Not long ago, getting a GLP-1 prescription often meant navigating insurance, finding a specialist, and waiting weeks for an appointment. Today, medications like semaglutide and tirzepatide are easier to access than ever before. You can obtain them from med spas, telehealth apps, online

Med Spa, Telehealth App, or Physician? Why Your Weight Loss Doctor’s Background Matters Read More »

Dr. Ann Czarnik, M.D., Austin weight loss physician, Amanecia Health

Semaglutide vs. Tirzepatide in Austin: An ER Doctor’s Guide to Choosing the Right Weight Loss Medication

Austin, National, Weight Loss Medication

By Ann Czarnik, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health If you’re looking into medical weight loss in Austin, you’ve probably seen two medication names everywhere: semaglutide and tirzepatide. You may know them better by the brand names used for diabetes and weight loss, but the real question most patients ask is simple:

Semaglutide vs. Tirzepatide in Austin: An ER Doctor’s Guide to Choosing the Right Weight Loss Medication Read More »

Ann Czarnik, M.D., board-certified emergency medicine physician and co-founder of Amanecia Health in Austin, Texas

What Is Concierge Medicine? A Guide for Austin Patients

Austin, Concierge Medicine, National

By Ann Czarnik, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health If you’ve heard the term concierge medicine but aren’t exactly sure what it means, you’re not alone. In Austin, the phrase is used to describe everything from traditional membership practices to telehealth apps that promise direct access to a doctor. Concierge medicine refers

What Is Concierge Medicine? A Guide for Austin Patients Read More »

Dr. Ann Czarnik, M.D., board-certified Emergency Medicine physician and co-founder of Amanecia Health

Brand-Name vs. Compounded GLP-1 Medications: What Your Doctor Should Be Telling You

National, Weight Loss Medication

By Ann Czarnik, M.D., FACEP — Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health If you’re researching GLP-1 weight loss medications, you’ve probably run into a confusing divide. On one side, there are brand-name medications like Wegovy, Ozempic, Mounjaro, and Zepbound — manufactured by Novo Nordisk and Eli Lilly, FDA-approved, and widely advertised. On the

Brand-Name vs. Compounded GLP-1 Medications: What Your Doctor Should Be Telling You Read More »

Physician reviewing FDA peptide regulatory updates and clinical research

FDA Peptide Reclassification 2026: What It Means for Patients — and Why Physician Oversight Matters More Than Ever

National, Wellness and Longevity

By the physicians of Amanecia Health | Updated April 27, 2026 Last reviewed June 18, 2026 by Ann Czarnik, M.D., FACEP. This page is maintained as a living reference and updated as the FDA process develops. Related: Read our follow-up on the NPR report on peptide restrictions and what it means for patients. On February

FDA Peptide Reclassification 2026: What It Means for Patients — and Why Physician Oversight Matters More Than Ever Read More »

Patient reviewing hormone monitoring with a physician during a telehealth visit

Effective Monitoring of Hormone Levels During Replacement Therapy

Hormone Replacement, National, Telemedicine Visits

By Ann Czarnik, M.D., FACEP, Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health Hormone therapy is only as good as the monitoring behind it. The dose that is right for you at the start is often not the dose that is right six months in, and the only way to know is to measure. Monitoring

Effective Monitoring of Hormone Levels During Replacement Therapy Read More »

Woman enjoying a healthy morning coffee in a modern kitchen setting.

Tirzepatide vs Traditional GLP-1 Agonists: Key Differences | Amanecia Health

Austin, Coastal Virginia, Dallas, Dallas-Fort Worth, Houston, National, Weight Loss Medication

Tirzepatide vs. Traditional GLP-1 Agonists: What’s the Difference? By Ann Czarnik, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health Patients ask me about tirzepatide and semaglutide almost every week now. The questions used to be “is this safe?” and “does it work?” The honest answers to both are yes, with caveats. The questions that

Tirzepatide vs Traditional GLP-1 Agonists: Key Differences | Amanecia Health Read More »